GSK Bolsters Oncology Portfolio with $10.6 Billion Acquisition of Nuvalent
In a move that signals a significant shift in its long-term growth strategy, GlaxoSmithKline (GSK) has officially announced a definitive...
In a move that signals a significant shift in its long-term growth strategy, GlaxoSmithKline (GSK) has officially announced a definitive...